New therapeutic approach for multidrug resistant pulmonary tuberculosis

Justina Antonela Dragomir; Silviu-Mihail Dumitru

doi:10.2478/pneum-2022-0024

.blurhash-client-img { display: none !important; }

New therapeutic approach for multidrug resistant pulmonary tuberculosis

Pneumologia

Volume 70 (2021): Issue 3 (October 2021)

By: Justina Antonela Dragomir and Silviu-Mihail Dumitru

Open Access

|Oct 2022

Abstract

Tuberculosis (TB) is an infectious and contagious disease caused by Mycobacterium tuberculosis, and it mainly affects the lungs. As Romania has consistently ranked first in the European Union (EU) in terms of the incidence and prevalence of TB in the past years, this paper aims to bring to the attention of physicians the new therapeutic regimens and ways to approach patients with multidrug resistant TB and extended resistance.

References

1. Strategia Națională de control a Tuberculozei în România 2015–2020. Bucuresti 2015 Ministerul Sănătății - Ordinul nr. 1171/21.09.2015.
Search in Google Scholar Back to article
2. Tuberculosis surveillance and monitoring in Europe 2021–2019 data. Surveillance report, 22 Mar 2021.
Search in Google Scholar Back to article
3. Brown EG, Dooley DS, Smith K. Drug-resistant Tuberculosis. A Survival Guide for Clinicians. 3rd ed. United States of America: CDPH Public Health; 2016. p. 2.
Search in Google Scholar Back to article
4. Norme Metodologice de implementare a Programului national de control al tuberculozei. București; 2008. p. 17.
Search in Google Scholar Back to article
5. A. Van Deun, T. Decroo, A. Piubello, B. C. de Jong, L. Lynen, H. L. Rieder, et al. Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs. Int J Tuberc Lung Dis. 2018; 22(3):239–245. Available from: doi.org/10.5588/ijtld.17.0660.
Open DOI Search in Google Scholar Back to article
6. WHO. Rapid Communication: key changes to treatment of multidrug- and rifampicin- resistant tuberculosis (MDR/RR-TB); August 2018.
Search in Google Scholar Back to article
7. WHO. WHO operational handbook on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. World Health Organization. Geneva, Switzerland, 2020. https://apps.who.int/iris/handle/10665/332398. License: CC BY-NC-SA 3.0 IGO.
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/pneum-2022-0024 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 106 - 110

Published on: Oct 21, 2022

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

drug resistant tuberculosis,

new therapeutic regimen

Related subjects:

Medicine,

Clinical medicine,

Clinical medicine, other,

Internal medicine,

Pneumology

© 2022 Justina Antonela Dragomir, Silviu-Mihail Dumitru, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 70 (2021): Issue 3 (October 2021)